We are live on ! Find out more
FFTY icon

CapForce IBD 50 ETF

40 hedge funds and large institutions have $31.5M invested in CapForce IBD 50 ETF in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

743% more call options, than puts

Call options by funds: $118K | Put options by funds: $14K

13% more capital invested

Capital invested by funds: $28M → $31.5M (+$3.51M)

0.96% more ownership

Funds ownership: 32.28%33.23% (+0.96%)

0% more funds holding

Funds holding: 4040 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

0% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 14

Holders
40
Holders Change
Holders Change %
0%
% of All Funds
0.58%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
5
Increased
14
Reduced
14
Closed
5
Calls
$118K
Puts
$14K
Net Calls
+$104K
Net Calls Change
+$70K
Name Holding Trade Value Shares
Change
Change in
Stake
IPW
1
IronBridge Private Wealth
Texas
$7.95M +$183K +6,999 +2%
LWM
2
LJI Wealth Management
Indiana
$3.91M +$7.29K +279 +0.2%
DSCM
3
Del-Sette Capital Management
New York
$3M +$282K +10,772 +11%
CPIG
4
Chicago Partners Investment Group
Illinois
$2.7M -$504K -19,265 -16%
Bank of America
5
Bank of America
North Carolina
$2.23M +$805K +30,789 +62%
Citadel Advisors
6
Citadel Advisors
Florida
$1.25M +$57K +2,179 +5%
Goldman Sachs
7
Goldman Sachs
New York
$1.02M +$968K +37,044 New
Osaic Holdings
8
Osaic Holdings
Arizona
$972K +$562K +21,490 +157%
IWM
9
IHT Wealth Management
Illinois
$957K +$13.6K +519 +2%
Two Sigma Advisers
10
Two Sigma Advisers
New York
$931K -$410K -15,700 -32%
LPL Financial
11
LPL Financial
California
$789K -$69.7K -2,668 -9%
Two Sigma Investments
12
Two Sigma Investments
New York
$763K -$159K -6,100 -18%
Jane Street
13
Jane Street
New York
$718K +$679K +25,985 New
Cambridge Investment Research Advisors
14
Cambridge Investment Research Advisors
Iowa
$628K -$20.9K -800 -3%
Marshall Wace
15
Marshall Wace
United Kingdom
$593K -$344K -13,164 -38%
TRCT
16
Tower Research Capital (TRC)
New York
$501K +$44.4K +1,699 +10%
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$433K -$557K -21,324 -58%
Wells Fargo
18
Wells Fargo
California
$398K +$42.8K +1,639 +13%
IFG
19
Independent Financial Group
California
$347K +$328K +12,540 New
BAM
20
Belpointe Asset Management
Nevada
$277K +$262K +10,021 New
AFS
21
AFG Fiduciary Services
Massachusetts
$234K
RJA
22
Raymond James & Associates
Florida
$219K -$55.7K -2,129 -21%
GIM
23
Grassi Investment Management
California
$206K +$195K +7,450 New
UBS Group
24
UBS Group
Switzerland
$154K +$5.57K +213 +4%
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
$74K -$270K -10,333 -79%

FFTY Hedge Fund Activity: Q1 2024 in Review

40 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD 50 ETF (FFTY) for Q1 2024, worth a combined $31.5M — up 13% from $28M a quarter earlier.

Fund positioning in FFTY was balanced in Q1 2024: 5 funds opened new positions, 5 closed out, 14 added to existing stakes and 14 trimmed.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $968K. The largest seller was Sowell Financial Services, exiting entirely with an estimated $1.78M sold.

  • 40 institutional investors held CapForce IBD 50 ETF (FFTY) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $31.5M of CapForce IBD 50 ETF stock for Q1 2024, up 13% quarter-over-quarter.
  • 5 funds opened new CapForce IBD 50 ETF positions in Q1 2024 and 5 closed out, a net change of 0 holders.
  • The largest CapForce IBD 50 ETF buyer in Q1 2024 was Goldman Sachs, an estimated $968K added.
  • The largest CapForce IBD 50 ETF seller in Q1 2024 was Sowell Financial Services, an estimated $1.78M sold.

Based on aggregated 13F filings for Q1 2024.